Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

28,041 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mechanochemically-induced glass formation from two-dimensional hybrid organic-inorganic perovskites.
Ye C, Lampronti GI, McHugh LN, Castillo-Blas C, Kono A, Chen C, Robertson GP, Nagle-Cocco LAV, Xu W, Stranks SD, Martinez V, Brekalo I, Karadeniz B, Užarević K, Xue W, Kolodzeiski P, Das C, Chater P, Keen DA, Dutton SE, Bennett TD. Ye C, et al. Among authors: xu w. Chem Sci. 2024 Apr 19;15(19):7198-7205. doi: 10.1039/d4sc00905c. eCollection 2024 May 15. Chem Sci. 2024. PMID: 38756817 Free PMC article.
Sintilimab (anti-PD-1 antibody) plus chidamide (histone deacetylase inhibitor) in relapsed or refractory extranodal natural killer T-cell lymphoma (SCENT): a phase Ib/II study.
Gao Y, He H, Li X, Zhang L, Xu W, Feng R, Li W, Xiao Y, Liu X, Chen Y, Wang X, Bai B, Wu H, Cai Q, Li Z, Li J, Lin S, He Y, Ping L, Huang C, Mao J, Chen X, Zhao B, Huang H. Gao Y, et al. Among authors: xu w. Signal Transduct Target Ther. 2024 May 17;9(1):121. doi: 10.1038/s41392-024-01825-0. Signal Transduct Target Ther. 2024. PMID: 38755119 Clinical Trial.
28,041 results
You have reached the last available page of results. Please see the User Guide for more information.